The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children
Year: 2005
Type: article
Source: Neuropsychopharmacology
Author: Donald F Klein
Institutions: New York State Psychiatric Institute, Columbia University
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
Funder: Pfizer
OpenAlex ID: W2046419548